BioCentury
ARTICLE | Clinical News

Paquinimod regulatory update

November 22, 2010 8:00 AM UTC

The COMP issued a positive opinion to grant Orphan Drug designation for Active Biotech's paquinimod to treat systemic sclerosis. The quinoline-3-carboxamide is in preclinical testing for the indicatio...